SCHEMBL30817391

SCHEMBL30817391

O=C1CCC(c2ccc(CN3CC4(CC(CO)C4)C3)cc2)C(=O)N1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.52
▸ DDB1 Q16531 18/20 0.52
▸ POLB P06746 1/20 0.42
▸ GSPT1 P15170 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30817400 0.87 CRBN (0.48) CRBNDDB1
SCHEMBL27293173 0.86 CRBN (0.52) CRBNDDB1POLBGSPT1
SCHEMBL30817346 0.82 CRBN (0.48) CRBNDDB1POLBGSPT1
SCHEMBL25217869 0.78 CRBN (0.64) CRBNDDB1POLBGSPT1
SCHEMBL31382367 0.77 CRBN (0.47) CRBNDDB1POLBGSPT1
SCHEMBL31111977 0.77 CRBN (0.44) CRBNDDB1POLB
SCHEMBL31111457 0.77 CRBN (0.44) CRBNDDB1POLB
SCHEMBL26641358 0.76 CRBN (0.64) CRBNDDB1POLBGSPT1
SCHEMBL25026494 0.76 CRBN (0.54) CRBNDDB1POLBGSPT1
SCHEMBL25831464 0.74 CRBN (0.57) CRBNDDB1POLBGSPT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059808-A1 WEE1 INHIBITORS AND METHODS FOR TREATING CANCER RECURIUM IP HOLDINGS, LLC (US) 2024-03-21 — — WO disclosed
Send feedback